Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Department of Veterans Affairs |
---|---|
Information provided by: | Department of Veterans Affairs |
ClinicalTrials.gov Identifier: | NCT00265538 |
This study examines the use of patient initiated discussions of blood pressure medication in the primary care setting. Additionally, this study examines different levels of patient incentive(s) to initiate discussions with providers including information only, information plus 20$ incentive and reimbursement for 6 months of copay, and information/monetary incentive plus a reminder call prior to the index visit. Patient opinions about doctor/patient relationships will be assessed. Provider attitudes and prescribing behaviors will be analyzed as well.
Condition | Intervention |
---|---|
Hypertension |
Behavioral: Pt. education to engage provider in hypertension treatment discussion Behavioral: Financial incentive & health educator phone call |
Study Type: | Interventional |
Study Design: | Randomized, Open Label, Active Control, Factorial Assignment, Efficacy Study |
Official Title: | Implementing Evidence-Based Treatment of Hypertension |
Estimated Enrollment: | 900 |
Study Start Date: | July 2006 |
Estimated Study Completion Date: | April 2009 |
Estimated Primary Completion Date: | April 2009 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
1
Patient Intervention arms: pure control (no intervention letter); intervention control (patient does not receive intervention letter, but provider sees other patients who may bring in letter); group a (intervention letter only); group b (intervention, + 20$ incentive for discussion w/ provider and 6 month copay reimbursement); group c (intervention letter, 20$ incentive for discussion w/ provider + copay reimbursement, plus reminder phone call 1-3 days prior to primary care visit).
|
Behavioral: Pt. education to engage provider in hypertension treatment discussion
Patients will receive a customized/tailored letter including most recent clinic blood pressure, current blood pressure medications and suggested htn medication(s)
Behavioral: Financial incentive & health educator phone call
Patients may receive 20$ for discussing the intervention letter with their provider and 6 months copay reimbursement and/or the 20$ discussion incentive, 6 months copay reimbursement as well as a phone call reminder 1-2 days prior to their primary care appt.
|
Patients will be randomized to Pure control, intervention control, intervention group a, intervention group b or intervention group c. Pure control patients will not receive any study information about diuretics and their providers will not see any patients who receive our study intervention letter. Patients in the intervention control group will not receive the intervention but will see providers who have other patients in the intervention groups. Patients in intervention group a will receive a customized letter prior to their next primary care appointment with information regarding the patient's specific blood pressure, current blood pressure medication and recommendation for switching or adding a thiazide. Patients in group b will receive the customized intervention letter as well as a 20$ incentive for discussing the information with their provider and a copay reimbursement for 6 months if a prescription is written for a thiazide. Patients in group c will receive the intervention letter, 20$ discussion incentive, copay reimbursement as well as a phone call reminder 1-2 days prior to their primary care visit.
Ages Eligible for Study: | 18 Years to 80 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
The eligible population includes patients less than 80 years of age enrolled in primary care clinics at the study sites that meet the following additional inclusion criteria:
Exclusion Criteria:
Patients meeting the above inclusion criteria will be excluded for the following reasons:
United States, Iowa | |
VA Medical Center, Iowa City | |
Iowa City, Iowa, United States, 52246-2208 | |
United States, Minnesota | |
VA Medical Center | |
Minneapolis, Minnesota, United States, 55417 |
Principal Investigator: | Peter J. Kaboli, MD MS | VA Medical Center, Iowa City |
Responsible Party: | Department of Veterans Affairs ( Kaboli, Peter - Principal Investigator ) |
Study ID Numbers: | IMV 04-066 |
Study First Received: | December 12, 2005 |
Last Updated: | September 15, 2008 |
ClinicalTrials.gov Identifier: | NCT00265538 |
Health Authority: | United States: Federal Government |
Hypertension Diuretics Drug Therapy Anti-Hypertensive Agents Patient Intervention |
Vascular Diseases Hypertension |
Cardiovascular Diseases |